Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Small. 2022 Oct 10;18(46):e2204941. doi: 10.1002/smll.202204941

Figure 1.

Figure 1.

Conceptual representation of artificial immune cell (or AI-cell) tool. (A) The initial design and synthesis of nucleic acid nanoparticles (NANPs) is followed by their physicochemical characterization and assessment of immunostimulatory potential to then be applied for predictive computational analysis of the NANPs immune responses. (B) The experimental workflow used for the development of AI-cell.